A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Cardiac Surgical ProceduresHemorrhage
Interventions
DEVICE

Veriset Hemostatic Patch

Topical hemostat

DEVICE

TachoSil®

Topical Hemostat

Trial Locations (12)

Unknown

Bonheiden

St Luc Hospital, Brussels

UZ Brussels, Brussels

Genk

Hassalt

Leuven

Dresden

Freiburg im Breisgau

Hamburg

Leipzig

Munich

Riga

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic - MITG

INDUSTRY

NCT01639833 - A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery | Biotech Hunter | Biotech Hunter